Cookie settings

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use iwcll.org, remember your settings and improve our services.

We also use cookies set by other sites to help us deliver content from their services.

View cookies
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Skip to main content
iwCLL logo
  • What is CLL?
  • About us
  • Our work
  • Education
  • Events
  • News
  • What is CLL?
  • About us
  • Our work
  • Education
  • Events
  • News
  1. Home
  2. Education
  3. CLL Digital Archive
  4. Subject

Interferon

The following items discuss clinical research and treatment on the drug interferon. For items related to general discussion of clinical research, see Clinical Research.

Vindesine Letter

Vindesine Letter

Letter discussing Galton’s opinion of Vindesine in treatment and the MRC Working Party’s interferon trials.

Doe Case Letter 2

Doe Case Letter 2

Letter providing an update on a patient with myeloma, alias Mr. Doe, whose disease had rapidly become highly aggressive. Weekly cyclophosphamide and prednisolone were no longer working, and Galton was giving him diamorphine for the pain, while considering treating Mr. Doe with interferon.

Share this page

In this section

  • Clinical Research
  • Cyclophosphamide
  • Idiotype
  • Immunoglobulin Mutational Status
  • Interferon
  • Lymphoproliferative Disorders
  • Mr. Doe
  • MRC Trial
  • Myeloproliferative Disorders
  • Origin
  • Publication
  • Retirement
  • Treatment
iwCLL logo

Sign up for updates from iwCLL

Join our mailing list (opens in new tab)

Follow us

  • Contact
  • Privacy
  • Cookies
  • Terms and conditions

Translate this site

Copyright © 2025 International Workshop on Chronic Lymphocytic Leukemia

Lovingly crafted by Mixd